Risk Communication Within Mexican-American Families
Completed
498 enrolled
MiGHT
Phase NA Completed
831 enrolled
CATALYST
Phase NA Completed
50 enrolled
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
500 enrolled
FEGALA
Phase NA Completed
411 enrolled
Second Opinions in Oncology
Completed
236 enrolled
PREPARE
Phase NA Completed
792 enrolled
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
KANSURVIVE
Phase NA Completed
15 enrolled 18 charts
Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
Completed
120 enrolled
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Phase 1 Completed
40 enrolled
Efficacy and Safety of Supervised Therapeutic Exercise in Cancer Patients With and Without Concurrent Treatment.
Phase NA Completed
78 enrolled
AH-HA
Phase NA Completed
600 enrolled
IMPLICATION
Completed
167 enrolled
GAP
Phase NA Completed
30 enrolled
Periop ctDNA
Completed
30 enrolled
QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Phase 1/2 Completed
43 enrolled 15 charts
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Phase 1 Completed
53 enrolled
INOVOLINE
Phase NA Completed
101 enrolled
IMPACTT
Phase NA Completed
274 enrolled
NAVIGATE
Phase 2 Completed
215 enrolled 3 FDA
AYAConnect
Phase NA Completed
63 enrolled
CALM: Managing Distress in Malignant Brain Cancer
Phase NA Completed
60 enrolled
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
Phase NA Completed
508 enrolled 8 charts
M-TICS
Phase NA Completed
44,601 enrolled
AVR-CHEMO
Phase NA Completed
150 enrolled
Study of ESG401 in Adults With Solid Tumors
Phase 1/2 Completed
156 enrolled
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
Completed
62 enrolled
EARN
Phase NA Completed
33 enrolled
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
Phase NA Completed
198 enrolled
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
OLAP
Completed
661 enrolled
CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer
Completed
32 enrolled
PRIORITY
Completed
346 enrolled 9 charts
EXERCISING TOGETHER for Couples Coping With Cancer
Phase NA Completed
496 enrolled 41 charts
A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE
Phase NA Completed
250 enrolled
NESTLE
Phase NA Completed
16 enrolled
P-COC
Phase NA Completed
60 enrolled
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
Phase 1 Completed
17 enrolled
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Completed
300 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers
Phase 1 Completed
64 enrolled
PREFER
Completed
1,429 enrolled
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
MOM
Completed
40 enrolled
Safety Study of MGAH22 in HER2-positive Carcinomas
Phase 1 Completed
66 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
K-DETEK
Completed
9,057 enrolled